The purchase will certainly assist BioNTech technology with its significant financial investment in cancer cells therapy, records Bloomberg Information.
发布者：BY MARKETWIRE，转转请注明出处：https://robotalks.cn/biontech-buys-former-vaccine-rival/
关于作者
GN replaces head of Hearing unit
上一篇
14 6 月, 2025 5:18 下午
Novo Nordisk to take important obesity hope to phase 3 trial
下一篇
14 6 月, 2025 5:18 下午
相关推荐
-
Gold at ‘multiples of $3,000’ possible, Sprott says
As gold costs remain to increase, having actually struck a brand-new document of $3,245.42 per oz. Monday, geopolitics and various other aspects can press yellow steel costs also g…
-
Badanie NIQ ujawnia nieznane wcześniej nastawienie konsumentów do reklam wygenerowanych przy użyciu sztucznej inteligencji
CHICAGO–( SERVICE CORD)– W czasie, gdy generatywna sztuczna inteligencja przesuwa granice w branżach kreatywnych, NielsenIQ (NIQ), czołowa światowa firma zajmująca się …
-
WiSA Technologies Executes $210 Million Definitive Agreement to Purchase Assets, Including High-Performance Computing (HPC) Software and Acoustic Technologies IP, from Data Vault Holdings Inc.
BEAVERTON, Ore.–(ORGANIZATION CORD)– WiSA Technologies Implements $210 Million Conclusive Arrangement to Acquisition Properties, consisting of HPC Software program and …
-
St George delivers maiden niobium numbers
Source is just one of minority innovative advancement alternatives internationally .
-
How to advance technology without cognitive overload
A brand-new paper checks out exactly how handling cognitive lots circulation is important for browsing intricate innovations and allowing their efficient usage.
